Snakebite envenomation (SBE) is a neglected disease causing annually 138,000 deaths worldwide. In Brazil, the genus Bothrops is responsible for 87% of these SBE. In this work, we assessed the extracts from the plants Aescululs hippocastanum (AH) and Melilotus officinalis (MO) to inhibit the plasma coagulant, proteolytic and phospholipase A2 (PLA2) activities of Bothrops jararaca, B. jararacussu, and B. neuwiedi venoms, as well as chemical characterization. The extracts from AH and MO were incubated with each venom for 30 min at 37 oC and then activities were assessed. AH inhibited 38% and 55% of the proteolytic activity of B. jararaca and B. neuwiedi venoms, respectively and MO inhibited 70% of this activity; but they failed to inhibit B. jararacussu venom. AH and MO inhibited more efficiently the B. jararaca- and B. neuwiedi venom-induced coagulation. AH and MO inhibited 60% of PLA2 of B. jararaca, 30% of B. jararacussu and 40% of B. neuwiedi activities. Overall, AH and MO inhibited with more efficacy the activities of B. jararaca and B. neuwiedi venoms. The extracts contain flavonoids, saponins, rosmarinic acid, quercetin, and phenolic acids. Thus, the work provided potential of these plants to complement commercial antivenoms against envenomation by Bothrops species.